Global 3D Bioprinting Technologies, Products and Key Application Areas 2017-2018 & Forecasts to 2035

Dublin, Dec. 21, 2017 (GLOBE NEWSWIRE) -- The "3D Bioprinting: Technologies, Products and Key Application Areas, (2nd Edition), 2018-2035" report has been added to Research and Markets' offering.

The 3D Bioprinting: Technologies, Products and Key Application Areas, (2nd Edition), 2018-2035' report provides a comprehensive study on the current market landscape of the 3D bioprinting industry, featuring an elaborate discussion on the future potential of this evolving market. The field has seen the emergence of many new players in the past few years; in fact, several well-known players of the 3D printing industry have broadened their focus to launch new initiatives specific to 3D bioprinting.

3D printing has garnered significant attention within the healthcare industry. The concept of 3D bioprinting was conceived in the late 1990s; since then, various industry stakeholders and academicians have undertaken several initiatives in order to further develop / improve this technology for a variety of applications. Organovo was the first company to enter the 3D bioprinting space by printing functional blood vessels in 2010. The company now offers 3D printed kidney and liver tissue models. There have been a number of other notable attempts to create fully functional 3D bioprinted tissues.

The current applications of 3D bioprinted products cater to various requirements within the pharmaceutical industry for clinical testing of therapeutic drugs. Owing to the evident interspecies differences, drug candidates that are shown to be efficacious in animal models often fail in humans. For such purposes, 3D bioprinting can be used to develop more accurate, human specific disease models. Further, there is a severe unmet need when it comes to organ transplants. Therefore, the ability to synthetically create organs for transplantation purposes is expected to generate a lot of interest amongst pharmaceutical / biotechnology players in the coming years.

The current market landscape of 3D bioprinting is characterized by the presence of nearly equal number of industry and non-industry players, featuring a number of startups and university spin-offs. Although there are several 3D bioprinting technologies already available, active efforts are being made to add to the intellectual property portfolio. The field has witnessed growing partnering activity and has also managed to capture the interest of both public and private sector investors.Despite certain challenges, several technical advancements and high unmet need of current patients waiting for organ transplants is anticipated to significantly drive future growth.

Amongst other things, the report features:

• A detailed overview of the current market landscape of 3D bioprinters and 3D bioprinted products, highlighting the contributions of industry and non-industry players, including information on the various technological aspects and key specifications of such technologies / products.
• Profiles of developers of bioprinting devices / technologies and bioprinted products. Each profile includes an overview of the company, information on their financials (wherever available), details on their respective product portfolios, 3D bioprinting specific collaborations, and an informed future outlook.
• A comprehensive product competitiveness analysis of existing 3D bioprinters, based on supplier power and product specific features such as type of technology and range of applications.
• An analysis of the partnerships that have been established in the recent past, covering research agreements, distribution agreements, product development agreements and other relevant deals, along with information on the collaborators / partners.
• An analysis of the investments made at various stages of development, such as seed financing, venture capital financing, debt financing, grants, capital raised from IPOs and subsequent offerings received by companies that are focused in this area.
• An analysis depicting the prevalent and emerging trends in 3D bioprinting as observed on the social media platform, Twitter. The report also includes a detailed case study on the upcoming trends, such as use of stem cells as bioinks, emergence of the concept of 4D bioprinting and commercialization of low-cost bioprinters, based on inputs from primary and secondary research.
• An analysis of intellectual property portfolio related to 3D bioprinting. The study presents a high-level view on the granted patents and submitted patent applications related to these technologies, highlighting the prevalent trends in this domain. In addition, the analysis highlights the most active geographies and the key players driving innovation in this field.

Key Topics Covered:

1. Preface

• Scope of the Report
• Research Methodology
• Chapter Outlines

2. Executive Summary

3. Introduction

• 3D Printing Technology
• 3D Bioprinting: Printing of Living Cells, Tissues and Organs

4. Market Landscape

• 3D Bioprinting: Overall Market Landscape
• 3D Bioprinters by Non-Industry Players
• 3D Bioprinted Products by Non-Industry Players

5. Company Profiles

• 3Dynamic Systems
• Aspect Biosystems
• Allevi (formerly BioBots)
• BioDan Group
• CELLINK
• EnvisionTEC
• GeSiM
• MEDPRIN BIOTECH
• microdrop Technologies
• MicroFab Technologies
• Nano3D Biosciences
• Organovo
• Qingdao Unique Products Develop
• regenHU
• SunP Biotech International

6. Recent Collaborations and Funding

• Partnership Models
• 3D Bioprinting: Recent Collaborations
• Venture Capital Interest
• Types of Funding
• 3D Bioprinting: Funding Instances

7. SWOT Analysis

8. Emerging Trends on Social Media

• Trends on Twitter
• Popular Keywords and Word Cloud Analysis

9. Recent Trends in 3D Bioprinting Industry

• Introduction of Scaffold-Free Bioprinting
• Emergence of 4D Bioprinting: the Next Generation of 3D Bioprinting
• Use of Stem Cells as Bio Ink
• Development of UV 3D Bioprinting, a Modified Stereolithography Approach
• Establishment of Spin-Offs of Academic Institutes
• Entry of Well-Established Players of 3D Printing Industry in Bioprinting Industry
• Introduction of Low-Priced Bioprinters
• Increasing Number of Initiatives Taken by Governments of Different Countries

10. Product Competitiveness Analysis

• 3D Bioprinters: 2 x 2 Product Competitiveness vs. Supplier Power Analysis

11. Patent Analysis

• 3D Bioprinting Patents: Distribution by Publication Year
• 3D Bioprinting Patents: Distribution by Geographical Location
• 3D Bioprinting Patents: Distribution by CPC Classifications
• 3D Bioprinting Patents: Emerging Areas
• 3D Bioprinting Patents: Leading Players

12. Market Forecast and Opportunity Analysis

• Forecast Methodology
• Overall 3D Bioprinting Market, 2018-2035
• 3D Bioprinting Market: Distribution by Applications
• 3D Bioprinting Market: Distribution by Region (North America, Europe, Asia Pacific and Rest of the World)
• 3D Bioprinting Market: Distribution by Technology (Extrusion, Inkjet, Laser and Others)

13. Conclusion

• 3D Bioprinting has Garnered Significant Attention within the Biopharmaceutical Industry
• The Competitive Market Landscape Features a Mix of Industry and Non-Industry Players
• North America and Europe Dominate the Current Market; Several Companies based in the Asia Pacific are also Making Notable Progress
• Research Continues to be the Major Focus as Stakeholders Strive to Improve Existing Methods and Technologies
• Increasing Partnership Activity and Financial Support from Public and Private Investors are Expected to Drive Growth
• Recent Advances are Expected to Act as Catalyst to the Success of 3D Bioprinting
• Inherent Challenges Must be Overcome to Tap the Multi-billion Dollar Opportunity in the Long Term

14. Interview Transcripts

• Douglas Chrisey, Professor, Tulane University
• Igor Zlatkin, Application Scientist and Chirantan Kanani, Technology & Product Development, Digilab
• Fanny Geraldo and Lisa Oliver, Researchers, University of Nantes
• Glauco R Souza, President & Chief Scientific Officer and Hubert Tseng, Senior Research Scientist, n3D Biosciences
• Kenneth Church, President & Chief Executive Officer and Xudong Chen, Executive Vice President Business Development & Sales, nScrypt
• Laura Bosworth, Chief Executive Officer & Co-Founder, TeVido BioDevices
• Lauralyn McDaniel, Industrial Manager, SME
• Marc Thurner, Chief Executive Officer, regenHU
• Roger Narayan, Professor, North Carolina State University
• Simon Fried, Chief Business Officer, Nano Dimension
• Anonymous, MicroFab Technologies

15. Appendix 1: Tabulated Data

16. Appendix 2: List of Companies and Organizations

• 3D Bioprinting Solutions
• 3D Systems
• 3Dynamic Systems
• 500 Startups
• Accellta
• Advanced Solutions
• Advanced Solutions Life Sciences
• Aether
• Albert Ludwig University of Freiburg
• AMBER (Advanced Materials and BioEngineering Research)
• American Process
• Amuza
• AO Research Institute Davos (ARI)
• Aprecia Pharmaceuticals
• Aquitaine Science Transfert
• ASI Life Sciences
• AxolotlBio
• Axolotl Biologix
• BASF
• Belgorod State University
• BellaSeno
• Ben Franklin Technology Partners
• Bio3D Technologies
• BioAdvance
• BioBots (Allevi)
• BioDan Group
• Bioftalmik
• Bioink Solutions
• BioServe Space Technologies
• Bone Therapeutics
• Bsing Dental and Implant Solutions
• Breakout Labs
• Brigham and Women's Hospital
• Brunel University London
• BTI Biotechnology Institute
• Cambridge University Hospitals
• Canada Foundation for Innovation (CFI)
• Captario
• Cardiovascular Innovation Institute (CII)
• Carnegie Mellon University
• Celgene
• Cell Applications
• CELLINK
• Censo Biotechnologies (previously Roslin Cellab)
• Center for Advancement of Science in Space (CASIS)
• Center for Gene and Cellular Therapies in the Treatment of Cancer (ONCOGEN)
• Cerhum
• Chalmers University of Technology
• Children's National Health System
• China Resources (Holdings)
• Chinese Academy of Engineering
• Chungnam National University Hospital
• Citizens Bank
• Clemson University
• Cold Springs Harbor Laboratory
• Collagen Solutions
• Columbia University
• Competence Centre TEDD (Tissue Engineering for Drug Development and Substance Testing)
• Cornell University
• Cosmo Bio
• CPA Group
• Crain's Detroit Business
• Cyfuse Biomedical
• Danske Bank
• DBJ Capital
• DePuy Synthes Companies
• DiethelmKellerSiberHegner (DKSH)
• DigiLab
• DreamIt
• Drexel University
• Eli Lilly
• Embrapa Genetic Resources and Biotechnology's Laboratory of Nanobiotechnology (LNANO)
• EnvisionTEC
• EpiBone
• ETH Zurich
• European Medicines Agency (EMA)
• Ewing Marion Kauffman Foundation
• Fernndez-Vega Foundation
• FLENI
• Flexadyne
• Flipkart
• Foley & Lardner LLP
• Forschungsinstitut fr Leder und Kunststoffbahnen
• Foundation for the Fight Against Infantile Neurological Diseases
• Founders Alliance
• Fraunhofer CMI
• Friedrich-Alexander-University of Erlangen-Nrnberg
• FUJIFILM Dimatix
• FundersClub
• GeSiM
• Glidewell
• GoPrint3D
• GreenByte AB
• Greiner Bio-One
• Hangzhou Electronic Science and Technology University
• Hannover Medical School
• Hanyang University
• Harvard Medical School
• Health Resources and Services Administration (HRSA)
• Heart Research Institute
• Helisys
• Helmholtz-Zentrum Dresden-Rossendorf (HZDR)
• Heriot-Watt University
• Hoffmann-La Roche
• Hogeschool Utrecht
• Hospital General Universitario Gregorio Maran
• Houston Methodist
• Humane Society International
• I&L Biosystems
• Image Analysis
• INVITRO
• Indiana University
• Indiegogo
• INNOTERE
• Innovate UK-MoST
• INSION
• Institute for Drug Safety Sciences
• Institute of Burn Research, Southwest Hospital
• International Society for Biofabrication (IBSF)
• International Space Station
• InvestX Capital
• Invetech
• IQ ARTISIA
• Izumi International
• JAFCO
• Janssen Research and Development
• Johns Hopkins University
• Johnson & Johnson
• Katholieke Universiteit Leuven
• Korea Institute of Machinery and Materials (KIMM)
• Korean Institute of Science and Technology (KIST)
• Labsun
• Le Vivier
• Life Science Nord group
• L'Oral
• Ludwig Maximilian University of Munich
• Luxexcel
• Maastricht University
• Made In Space
• MakerBot
• MaRS Innovation
• Mass Innovation Labs
• Massachusetts Institute of Technology (MIT)
• Mayo Clinic
• McGill University Health Centre
• McMaster University
• Medical University of South Carolina
• Medicrea
• MedImmune
• MEDPRIN BIOTECH
• Med-Tech Innovation
• Merck & Co
• Merrill Corporation
• Metabridge
• Methuselah Foundation
• microdrop Technologies
• MicroFab Technologies
• MIDSCI
• Mode Diagnostics
• Morriston Hospital
• Moss Enterprises
• Murdoch Children's Research Institute (MCRI)
• MUSC Bioprinting Research Center
• My Doctor
• n3D Biosciences
• Nano Dimension
• Nanyang Technological University
• NASA
• National Cancer Institute
• National Center for Advancing Translational Sciences (NCATS)
• National Eye Institute (NEI)
• National Institutes of Health (NIH)
• National Medical Research Radiological Centre of the Ministry of Health of the RussianFederation
• National Research Council-Industry Research Assistance Program (NRC-IRAP)
• National Science Foundation (NSF)
• National University of Singapore (NUS)
• Neatco
• NetScientific
• Neutec Group
• New Ventures BC
• Newcastle University
• News/Talk 760 WJR
• NextGene Biosystem
• Nike
• Nippon Venture Capital
• Northeastern University
• Northwestern University
• Novartis
• nScrypt
• NSF Frontiers in Integrative Biological Research
• NSF SBIR
• Objet Geometries
• Ohio State University
• OHSU Knight Cancer Institute
• Oregon Health & Science University (OHSU)
• Organovo
• Ortho Baltic Group
• Ourobotics
• Oxford MEStar
• OxSyBio
• Pandorum Technologies
• Pennsylvania State University
• PeptiGelDesign Technologies
• Phonak
• Plum Alley Investments
• Poietis
• Praxis Pharmaceutical
• Precise Bio
• Pressure BioSciences
• Princeton University
• ProtoSpace Foundation
• Qingdao Unique Products Develop
• Queensland University of Technology
• Rainbow Biosciences
• Range of Motion Project (ROMP)
• RBC Royal Bank
• REGEMAT 3D
• regenHU
• Regenovo Biotechnology (subsidiary of Shining3D)
• ReproCELL Group
• RESAAS Services
• Research Centre for Energy, Environment and Technology (CIEMAT)
• Rice University
• Ricoh
• Roche
• Rokit
• RoosterBio
• Royan Institute
• R-Pharm
• Russian Medical Academy of Postgraduate Education Studies
• Sahlgrenska Academy
• Samsara Sciences
• Sanford Consortium for Regenerative Medicine
• Sanitas International
• SAP America
• SBH Sciences
• ScanSource
• Sciperio
• Scripps Clinic
• Seoul National University Bundang Hospital
• Seoul National University of Science and Technology
• Seraph Robotics
• Shanghai Jiao Tong University
• Shanghai Man Heng Digital Technology
• Shapeways
• Shibuya Kogyo
• Sichuan Revotek
• Siemens
• Silentys (Zeltia Group)
• Sirris
• Skinprint
• Skolkovo Innovation Centre
• Solidscape
• Somos
• South by Southwest SXSW Accelerator
• Spanish National Research Council
• SPIRE Bioventures
• Stanford University
• Stem Cell Network
• Stemorgan Therapeutics
• SternAegis Ventures
• Stratasys
• Sunnybrook Health Sciences Centre
• SunP Biotech International
• Swansea University Medical School
• Swiss Center for Electronics and Microtechnology
• Symme 3D
• Tanner Friedman
• Technical University of Munich (TUM)
• TeViDo BioDevices
• The Finnish Funding Agency for Innovation
• The Scripps Research Institute
• The Trade & Industry Group of Gothenburg&Co
• The University of Virginia
• The Welsh Centre for Burns and Plastic Surgery
• The Welsh Centre for Printing and Coating
• ThermoFisher Scientific
• Tiffany & Co
• Tissue Engineering and Regenerative Medicine International Society
• Trideo
• Tsinghua University
• Tufts University
• UMC Utrecht
• UniQuest
• United Rocket and Space Corporation
• Universidad Carlos III de Madrid
• Universit catholique de Louvain
• University College of London
• University of Antwerp
• University of Bath
• University of Bayreuth
• University of Bordeaux
• University of British Columbia
• University of California
• University of Cambridge
• University of Colorado
• University of Dayton
• University of Eastern Finland
• University of Exeter
• University of Iowa College of Engineering
• University of Liverpool
• University of Louisville
• University of Manchester
• University of Manitoba
• University of Maryland
• University of Minnesota
• University of Missouri
• University of North Carolina
• University of Nottingham
• University of Otago, Christchurch
• University of Pennsylvania
• University of Pisa
• University of Sheffield
• University of South Australia (UniSA)
• University of South Carolina
• University of Southampton
• University of Texas at San Antonio (UTSA)
• University of Tokyo
• University of Tokyo Edge Capital
• University of Toronto
• University of Victoria
• University of Washington
• University of Waterloo
• University of Wollongong
• University of Zurich
• University Santiago de Compostela
• USFDA
• Utrecht3DMedical (University Medical Center Utrecht)
• VisualPing
• Vivos Dental
• Wake Forest Baptist Medical Center
• Wake Forest Institute for Regenerative Medicine
• Wallenberg Wood Science Center
• Watson Research Center
• WiSEED
• Wyss Institute (Harvard University)
• Xanofi
• Xilloc
• Yale School of Medicine
• Yale University
• Z Corporation
• Zeev Bregman
• Zeltia Group
• ZenBio
• Zurich University of Applied Sciences (ZHAW)
• Zyomic Technologies

For more information about this report visit https://www.researchandmarkets.com/research/dlfc56/global_3d?w=12

                    
                    
                    CONTACT: Research and Markets
                             Laura Wood, Senior Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                             Related Topics: 3D Printing, Biomaterials